Skip to main content
SpringerLink
Log in

What is in a name? Does cancer subtyping help or hinder in epidemiology research?

  • COMMENTARY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. Br Med J. 1950;2(4682):739–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. Br Med J. 1954;1(4877):1451–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking: a second report on the mortality of British doctors. Br Med J. 1956;2(5001):1071–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Doll R, Hill AB, Kreyberg L. The significance of cell type in relation to the aetiology of lung cancer. Br J Cancer. 1957;11(1):43–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950;143(4):329–36.

    Article  CAS  PubMed  Google Scholar 

  6. Lewis DR, Check DP, Caporaso NE, Travis WD, Devesa SS. US lung cancer trends by histologic type. Cancer. 2014;120(18):2883–92.

    Article  PubMed  PubMed Central  Google Scholar 

  7. McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19(2):223–38.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kurzrock R, Giles FJ. Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes. Cell Cycle. 2015;14(14):2219–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hyman DM, Puzanov I, Subbiah V, Faris JE, Chau I, Blay JY, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. N Engl J Med. 2015;373(8):726–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hunter DJ, D’Agostino RB Sr. Let’s not put all our eggs in one basket. N Engl J Med. 2015;373(8):691–3.

    Article  PubMed  Google Scholar 

  11. Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106(8):dju165. doi:10.1093/jnci/dju165.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Richiardi L, Barone-Adesi F, Pearce N. Cancer subtypes in etiologic research. Eur J Epidemiol. 2017;. doi:10.1007/s10654-017-0253-z.

    PubMed  Google Scholar 

  13. Vandenbroucke JP, Broadbent A, Pearce N. Causality and causal inference in epidemiology: the need for a pluralistic approach. Int J Epidemiol. 2016;45(6):1776–86.

    Article  PubMed  Google Scholar 

  14. Campbell JD, Mazzilli SA, Reid ME, Dhillon SS, Platero S, Beane J, Spira AE. The case for a Pre-Cancer Genome Atlas (PCGA). Cancer Prev Res (Phila). 2016;9(2):119–24. doi:10.1158/1940-6207.CAPR-16-0024.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuffield Department of Population Health, University of Oxford, Oxford, UK

    David J. Hunter

  2. Harvard TH Chan School of Public Health, Boston, MA, USA

    David J. Hunter

Authors
  1. David J. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Hunter.

Ethics declarations

Conflict of interest

The author declares he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hunter, D.J. What is in a name? Does cancer subtyping help or hinder in epidemiology research?. Eur J Epidemiol 32, 349–351 (2017). https://doi.org/10.1007/s10654-017-0274-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-017-0274-7

Keywords

Search

Navigation